

NCT02462590 comparison:

Summary:
CHIA has 11 criteria while your personal folder has 11 criteria
Total found criteria: 11/11
Total not Found: 0/11
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Adults = 18 years of age                           │ Adults ≥ 18 years of age                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Admitted to any ICU and receiving invasive         │ Admitted to any ICU and receiving invasive         │
│ mechanical ventilation                             │ mechanical ventilation                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Anticipated ventilation of =72 hours at the time   │ Anticipated ventilation of ≥72 hours at the time   │
│ of screening, as per the ICU physician             │ of screening, as per the ICU physician             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Invasively mechanically ventilated >72 hours at    │ Invasively mechanically ventilated \>72 hours at   │
│ the time of screening                              │ the time of screening                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients at potential increased risk of iatrogenic │ Patients at potential increased risk of iatrogenic │
│ probiotic infection (see Section 2.6 for detailed  │ probiotic infection (see Section 2.6 for detailed  │
│ explanation) including specific immunocompromised  │ explanation) including specific immunocompromised  │
│ populations (HIV <200 CD4 cells/µL, those          │ populations (HIV \<200 CD4 cells/μL, those         │
│ receiving chronic immunosuppressive medications    │ receiving chronic immunosuppressive medications    │
│ (e.g., azathioprine, cyclosporine,                 │ (e.g., azathioprine, cyclosporine,                 │
│ cyclophosphamide, tacrolimus, methotrexate,        │ cyclophosphamide, tacrolimus, methotrexate,        │
│ mycofenolate, Anti-IL2), previous transplantation  │ mycofenolate, Anti-IL2), previous transplantation  │
│ (including stem cell) at any time, malignancy      │ (including stem cell) at any time, malignancy      │
│ requiring chemotherapy in the last 3 months,       │ requiring chemotherapy in the last 3 months,       │
│ neutropenia [absolute neutrophil count < 500]).    │ neutropenia \[absolute neutrophil count \< 500\]). │
│ However, patients receiving corticosteroids        │ However, patients receiving corticosteroids        │
│ previously or presently or projected to receive    │ previously or presently or projected to receive    │
│ corticosteroids are not excluded                   │ corticosteroids are not excluded                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients at risk for endovascular infection        │ Patients at risk for endovascular infection        │
│ (previously documented rheumatic heart disease,    │ (previously documented rheumatic heart disease,    │
│ congenital valve disease, surgically repaired      │ congenital valve disease, surgically repaired      │
│ congenital heart disease, unrepaired cyanotic      │ congenital heart disease, unrepaired cyanotic      │
│ congenital heart disease, any intracardiac repair  │ congenital heart disease, any intracardiac repair  │
│ with prosthetic material [mechanical or bio-       │ with prosthetic material \[mechanical or bio-      │
│ prosthetic cardiac valves], previous or current    │ prosthetic cardiac valves\], previous or current   │
│ endocarditis, permanent endovascular devices       │ endocarditis, permanent endovascular devices       │
│ (e.g., endovascular grafts [e.g., aortic aneurysm  │ (e.g., endovascular grafts \[e.g., aortic aneurysm │
│ repair, stents involving large arteries such as    │ repair, stents involving large arteries such as    │
│ aorta, femorals and carotids], inferior vena cava  │ aorta, femorals and carotids\], inferior vena cava │
│ filters, dialysis vascular grafts), tunnelled (not │ filters, dialysis vascular grafts), tunnelled (not │
│ short-term) hemodialysis catheters, pacemakers or  │ short-term) hemodialysis catheters, pacemakers or  │
│ defibrillators. Patients with temporary central    │ defibrillators. Patients with temporary central    │
│ venous catheters, central venous dialysis          │ venous catheters, central venous dialysis          │
│ catheters or peripherally inserted central         │ catheters or peripherally inserted central         │
│ catheters (PICCs) are not excluded and patients    │ catheters (PICCs) are not excluded and patients    │
│ with coronary artery stents, coronary artery       │ with coronary artery stents, coronary artery       │
│ bypass grafts (CABG) or neurovascular coils are    │ bypass grafts (CABG) or neurovascular coils are    │
│ not excluded; patients with mitral valve prolapse  │ not excluded; patients with mitral valve prolapse  │
│ or bicuspid aortic valve are not excluded          │ or bicuspid aortic valve are not excluded          │
│ providing they have no other exclusion criteria    │ providing they have no other exclusion criteria    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a primary diagnosis of severe acute  │ Patients with a primary diagnosis of severe acute  │
│ pancreatitis, without reference to a Ranson score  │ pancreatitis, without reference to a Ranson score  │
│ [Ranson 1974]). However, patients with mild or     │ \[Ranson 1974\]). However, patients with mild or   │
│ moderate pancreatitis are not excluded             │ moderate pancreatitis are not excluded             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with percutaneous gastric or jejunal      │ Patients with percutaneous gastric or jejunal      │
│ feeding tubes already in situ as per Health Canada │ feeding tubes already in situ as per Health Canada │
│ guidance                                           │ guidance                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Strict contraindication or inability to receive    │ Strict contraindication or inability to receive    │
│ enteral medications                                │ enteral medications                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Intent to withdraw advanced life support as per    │ Intent to withdraw advanced life support as per    │
│ the ICU physician                                  │ the ICU physician                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous enrolment in this or current enrolment in │ Previous enrolment in this or current enrolment in │
│ a potentially confounding tria                     │ a potentially confounding tria                     │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛